跳转至内容
Merck
CN

主要文件

查看所有文档

15518

Boc-Inp-OH

≥99.0% (HPLC)

别名:

1-Boc-4-哌啶甲酸, N-Boc-异六氢烟碱酸

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C11H19NO4
化学文摘社编号:
84358-13-4
分子量:
229.27
NACRES:
NA.22
PubChem Substance ID:
329750921
eCl@ss:
32160406
UNSPSC Code:
12352209
MDL number:
MFCD00076999
Beilstein/REAXYS Number:
5533442
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

100

assay

≥99.0% (HPLC)

form

solid

reaction suitability

reaction type: Boc solid-phase peptide synthesis

application(s)

peptide synthesis

SMILES string

CC(C)(C)OC(=O)N1CCC(CC1)C(O)=O

InChI

1S/C11H19NO4/c1-11(2,3)16-10(15)12-6-4-8(5-7-12)9(13)14/h8H,4-7H2,1-3H3,(H,13,14)

InChI key

JWOHBPPVVDQMKB-UHFFFAOYSA-N

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCC8589
BCBL0287V
1436223V
1436223
1362670

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Xunan Jing et al.
Nanoscale, 11(33), 15508-15518 (2019-08-09)
Although the collaborative therapy of chemotherapy (CT) and photodynamic therapy (PDT) is much more efficient for tumor treatment than monotherapies, premature leakage of drugs from nanocarriers and hypoxia in the tumor microenvironment (TME) result in systemic toxicity and suboptimal therapy
Jing Zhang et al.
Cell death and differentiation, 27(5), 1569-1587 (2019-10-28)
Microtubule-targeting agents (MTAs) are a class of most widely used chemotherapeutics and their mechanism of action has long been assumed to be mitotic arrest of rapidly dividing tumor cells. In contrast to such notion, here we show-in many cancer cell

全球贸易项目编号

货号GTIN
15518-5G04061832593838